Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.

[1]  K. Blum,et al.  Morphine suppression of ethanol withdrawal in mice , 1976, Experientia.

[2]  N. Volkow,et al.  Overexpression of dopamine D2 receptors reduces alcohol self‐administration , 2001, Journal of neurochemistry.

[3]  D. van der Kooy,et al.  The D2 receptor is critical in mediating opiate motivation only in opiate‐dependent and withdrawn mice , 2001, The European journal of neuroscience.

[4]  D. Vlahov,et al.  Injecting misuse of buprenorphine among French drug users. , 2001, Addiction.

[5]  Thomas J. H. Chen,et al.  The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors , 2000, Journal of psychoactive drugs.

[6]  E P Noble,et al.  The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. , 2000, American journal of medical genetics.

[7]  K. Preston,et al.  Naltrexone shortened opioid detoxification with buprenorphine. , 1999, Drug and alcohol dependence.

[8]  G. Hulse,et al.  Reassessing naltrexone maintenance as a treatment for illicit heroin users , 1999 .

[9]  H. Kranzler,et al.  Sustained-release naltrexone for alcoholism treatment: a preliminary study. , 1998, Alcoholism, clinical and experimental research.

[10]  P. Sokoloff,et al.  Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence , 1998, Molecular Psychiatry.

[11]  J. Norbeck,et al.  Naltrexone as an adjunctive treatment for older patients with alcohol dependence. , 1997, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[12]  D. Collier,et al.  Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects , 1997, Molecular Psychiatry.

[13]  J. Volpicelli,et al.  Naltrexone biotransformation and incidence of subjective side effects: a preliminary study. , 1997, Alcoholism: Clinical and Experimental Research.

[14]  D. Oslin,et al.  Tolerability of naltrexone in treating older, alcohol-dependent patients. , 1997, The American journal on addictions.

[15]  R. Ebstein,et al.  Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects , 1997, Molecular Psychiatry.

[16]  A. Herz.  Endogenous opioid systems and alcohol addiction , 1997, Psychopharmacology.

[17]  E. Noble,et al.  [3H]Naloxone binding in the human brain: alcoholism and theTaqI A D2 dopamine receptor polymorphism , 1996, Brain Research.

[18]  J. Volpicelli,et al.  Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment. , 1995, Alcohol and alcoholism.

[19]  B. Mason,et al.  A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence , 1994 .

[20]  E. Witztum,et al.  The efficacy of naltrexone in preventing reabuse of heroin after detoxification , 1994, Biological Psychiatry.

[21]  B. Rounsaville,et al.  Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.

[22]  A. Alterman,et al.  Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.

[23]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.

[24]  K. Blum,et al.  Allelic association of human dopamine D2 receptor gene in alcoholism. , 1990, JAMA.

[25]  K. Blum,et al.  Opioid peptides and alcoholism: genetic deficiency and chemical management. , 1986, Functional neurology.

[26]  K. Blum,et al.  Ethanol acceptance as a function of genotype amounts of brain [Met]enkephalin. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Sinforiani,et al.  Central Deficiency of β-Endorphin in Alcohol Addicts , 1982 .

[28]  M. Sar,et al.  Reduced leucine-enkephalin--like immunoreactive substance in hamster basal ganglia after long-term ethanol exposure. , 1982, Science.

[29]  A. Ho,et al.  Suppression of ethanol consumption by MET‐enkephalin in rats , 1982, The Journal of pharmacy and pharmacology.

[30]  K. Blum,et al.  Ethanol intoxication as function of genotype dependent responses in three inbred mice strains , 1982, Pharmacology Biochemistry and Behavior.

[31]  K. Blum,et al.  Psychogenetics of drug seeking behavior. , 1980, Substance and alcohol actions/misuse.

[32]  K. Blum,et al.  Alcohol euphoria: possible mediation via endorphinergic mechanisms. , 1979, Journal of psychedelic drugs.

[33]  R. D. Myers,et al.  Alcohol drinking: abnormal intake caused by tetrahydropapaveroline in brain. , 1977, Science.

[34]  H. Schwertner,et al.  Naloxone-induced inhibition of ethanol dependence in mice , 1977, Nature.

[35]  K. Blum,et al.  Alcohol and opiates : neurochemical and behavioral mechanisms , 1977 .

[36]  I. Geller,et al.  Ethanol preference in the hamster: effects of morphine sulfate and naltrexone, a long-acting morphine antagonist. , 1976, Proceedings of the Western Pharmacology Society.

[37]  I. Geller,et al.  Diethanolamine: a possible weak agonist-antagonist to ethanol. , 1972, European journal of pharmacology.